Detalles de la búsqueda
1.
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Blood
; 136(9): 1091-1104, 2020 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438407
2.
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
PLoS Med
; 18(1): e1003454, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428632
3.
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Br J Haematol
; 192(5): 853-868, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656799
4.
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Haematologica
; 106(7): 1957-1967, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499244
5.
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection.
Eur Respir J
; 56(5)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32616595
6.
Subclonal TP53 copy number is associated with prognosis in multiple myeloma.
Blood
; 132(23): 2465-2469, 2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373884
7.
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Hum Genomics
; 13(1): 37, 2019 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31429796
8.
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(1): 57-73, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559051
9.
Neutral tumor evolution in myeloma is associated with poor prognosis.
Blood
; 130(14): 1639-1643, 2017 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827410
10.
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.
Haematologica
; 104(7): 1440-1450, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733268
11.
Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
Br J Haematol
; 182(6): 816-829, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984830
12.
Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.
Br J Haematol
; 178(2): 220-230, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573706
13.
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction.
Blood
; 125(12): 1932-5, 2015 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645353
14.
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System.
Blood
; 126(17): 1996-2004, 2015 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26330243
15.
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.
Blood
; 125(5): 831-40, 2015 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25428216
16.
Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling.
Breast Cancer Res Treat
; 155(2): 303-11, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26783036
17.
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome.
Blood
; 123(22): 3414-9, 2014 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24733348
18.
The impact of response on bone-directed therapy in patients with multiple myeloma.
Blood
; 122(17): 2974-7, 2013 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23974194
19.
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
Br J Haematol
; 166(1): 109-17, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24673708
20.
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.
Blood
; 119(23): 5374-83, 2012 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22498739